Flagship Pioneering, a US-based bioplatform innovation company, announced on Tuesday that it has named David Khougazian as its new growth partner.

In the new role, Khougazian will help scale and grow various Flagship-founded companies, working together with leaders at Flagship and its ecosystem of companies on organisational development, long-term strategy, financing, and business development.

Khougazian has served at Sanofi for more than two decades. He also held the position of CEO of Sanofi Pasteur MSD and earlier as chief of staff to the Sanofi CEO. He has served as vice president and head of Mergers and Acquisitions at Aventis Pharmaceuticals and started his career at HSBC where he managed a range of diversified financial assets.

Noubar Afeyan, PhD, Flagship Pioneering founder and CEO, said: "David has deep experience developing and advancing healthcare companies by harnessing innovation partnerships. I am pleased to welcome David to our team to help progress our companies as they create value and growth."